AbGenomics International's Series B Round

AbGenomics International raised a round of funding on July 19, 2013.

AbGenomics International is a biopharmaceutical company focused on the discovery and development of medicines to treat diseases with unmet medical need and significant market potential. The company ha…

Articles about AbGenomics International's Series B Round: